These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28242140)

  • 41. Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer.
    La Rosa A; Mittauer KE; Chuong MD; Hall MD; Kutuk T; Bassiri N; McCulloch J; Alvarez D; Herrera R; Gutierrez AN; Tolakanahalli R; Mehta MP; Kotecha R
    Med Dosim; 2023 Winter; 48(4):238-244. PubMed ID: 37330328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-
    Wee CW; An HJ; Kang HC; Kim HJ; Wu HG
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818787383. PubMed ID: 30012039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What do radiation oncologists require for future advancements in lung SBRT?
    Ricardi U; Badellino S; Filippi AR
    Phys Med; 2017 Dec; 44():150-156. PubMed ID: 27914779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential reduction of lung dose via VMAT with jaw tracking in the treatment of single-isocenter/two-lesion lung SBRT.
    Pokhrel D; Sanford L; Halfman M; Molloy J
    J Appl Clin Med Phys; 2019 May; 20(5):55-63. PubMed ID: 30955251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
    Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience.
    Wurm RE; Gum F; Erbel S; Schlenger L; Scheffler D; Agaoglu D; Schild R; Gebauer B; Rogalla P; Plotkin M; Ocran K; Budach V
    Acta Oncol; 2006; 45(7):881-9. PubMed ID: 16982554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.
    Simeonova-Chergou A; Jahnke A; Siebenlist K; Stieler F; Mai S; Boda-Heggemann J; Wenz F; Lohr F; Jahnke L
    Strahlenther Onkol; 2016 Mar; 192(3):166-73. PubMed ID: 26780654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.
    Taremi M; Hope A; Dahele M; Pearson S; Fung S; Purdie T; Brade A; Cho J; Sun A; Bissonnette JP; Bezjak A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):967-73. PubMed ID: 21377293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional Image-guided Radiotherapy Planning for Normal Lung Avoidance.
    Ireland RH; Tahir BA; Wild JM; Lee CE; Hatton MQ
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):695-707. PubMed ID: 27637724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.
    Teh BS; Paulino AC; Lu HH; Chiu JK; Richardson S; Chiang S; Amato R; Butler EB; Bloch C
    Technol Cancer Res Treat; 2007 Aug; 6(4):347-54. PubMed ID: 17668943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reducing the dose of gadolinium-based contrast agents for DCE-MRI guided SBRT: The effects on inter and intra observer variability for preoperative target volume delineation in early stage breast cancer patients.
    Mouawad M; Biernaski H; Brackstone M; Lock M; Yaremko B; Sexton T; Yu E; Dinniwell RE; Lynn K; Hajdok G; Prato FS; Thompson RT; Gelman N; Gaede S
    Radiother Oncol; 2019 Feb; 131():60-65. PubMed ID: 30773188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
    Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
    Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stereotactic body radiotherapy for early-stage lung cancer: a systematic review on the choice of photon energy and linac flattened/unflattened beams.
    Gill A; Hirst AL; Rowshanfarzad P; Gill S; Bucknell N; Dass J; Sabet M
    Radiat Oncol; 2024 Jan; 19(1):1. PubMed ID: 38167095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initial clinical observations of intra- and interfractional motion variation in MR-guided lung SBRT.
    Thomas DH; Santhanam A; Kishan AU; Cao M; Lamb J; Min Y; O'Connell D; Yang Y; Agazaryan N; Lee P; Low D
    Br J Radiol; 2018 Feb; 91(1083):20170522. PubMed ID: 29166129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of IGRT-Induced Imaging Doses and Secondary Cancer Risk for SBRT Early Lung Cancer Patients In Silico Study.
    Duan YH; Gu HL; Yang XH; Chen H; Wang H; Shao Y; Li XY; Feng AH; Ying YC; Fu XL; Ma K; Zhou T; Xu ZY
    Technol Cancer Res Treat; 2021; 20():15330338211016472. PubMed ID: 34184567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance.
    Kestin L; Grills I; Guckenberger M; Belderbos J; Hope AJ; Werner-Wasik M; Sonke JJ; Bissonnette JP; Xiao Y; Yan D;
    Radiother Oncol; 2014 Mar; 110(3):499-504. PubMed ID: 24630539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Silico Trial of MR-Guided Midtreatment Adaptive Planning for Hypofractionated Stereotactic Radiation Therapy in Centrally Located Thoracic Tumors.
    Henke LE; Kashani R; Hilliard J; DeWees TA; Curcuru A; Przybysz D; Green O; Robinson CG; Bradley JD
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):987-995. PubMed ID: 29953910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
    Zhang X; Liu H; Balter P; Allen PK; Komaki R; Pan T; Chuang HH; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1558-65. PubMed ID: 22572078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.